Form D · Biotechnology
HERON THERAPEUTICS, INC. /DE/
San Diego, CA · CIK 0000818033
Offering snapshot reported Aug 1, 2023 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 25, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 1, 2023 | Initial | $30,000,000 | No comparison | 7 | SEC filing |
| Aug 10, 2012 | Initial | $53,549,999 | No comparison | 21 | SEC filing |
| Jul 11, 2011 | Initial | $24,000,001 | No comparison | 22 | SEC filing |
| May 13, 2011 | Initial | $1,500,000 | No comparison | 4 | SEC filing |
| Nov 5, 2009 | Initial | $8,142,817 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-488462
Source: Form D, filed Aug 1, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael A. Adam | Executive |
| John Barr | Executive |
| Craig Collard | Director, Executive |
| Stephen R. Davis | Director |
| Sharmila Dissanaike | Director |
| Ira Duarte | Executive |
| Paul Goddard | Director |
| Craig Johnson | Director |
| Kevin Kotler | Director |
| Adam Morgan | Director |
| Thomas Ottoboni | Executive |
| Ronald Prentki | Director, Executive |
| Barry D. Quart | Director |
| Susan Rodriguez | Director |
| Robert Rosen | Director |
| Toby Rosenblatt | Director |
| Kevin C. Tang | Director |
| Gregory C. Turnbull | Director |
| Christian Waage | Director |
| John B. Whelan | Director, Executive |
| Robert Zerbe | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4242 Campus Point Court Suite 200
San Diego, CA, 92121
San Diego, CA, 92121